STRATA Skin Sciences Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 123/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 7.40.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
STRATA Skin Sciences Inc's Score
Industry at a Glance
Industry Ranking
123 / 206
Overall Ranking
291 / 4562
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
7.400
Target Price
+436.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
STRATA Skin Sciences Inc Highlights
StrengthsRisks
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Growing
The company is in a growing phase, with the latest annual income totaling USD 33.56M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 33.56M.
Overvalued
The company’s latest PE is -0.48, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.60M shares, decreasing 6.19% quarter-over-quarter.
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Ticker SymbolSSKN
CompanySTRATA Skin Sciences Inc
CEORafaeli (Dolev)
Websitehttps://www.strataskinsciences.com/
FAQs
What is the current price of STRATA Skin Sciences Inc (SSKN)?
The current price of STRATA Skin Sciences Inc (SSKN) is 1.270.
What is the symbol of STRATA Skin Sciences Inc?
The ticker symbol of STRATA Skin Sciences Inc is SSKN.
What is the 52-week high of STRATA Skin Sciences Inc?
The 52-week high of STRATA Skin Sciences Inc is 3.860.
What is the 52-week low of STRATA Skin Sciences Inc?
The 52-week low of STRATA Skin Sciences Inc is 1.240.
What is the market capitalization of STRATA Skin Sciences Inc?
The market capitalization of STRATA Skin Sciences Inc is 6.69M.
What is the net income of STRATA Skin Sciences Inc?
The net income of STRATA Skin Sciences Inc is -10.09M.
Is STRATA Skin Sciences Inc (SSKN) currently rated as Buy, Hold, or Sell?
According to analysts, STRATA Skin Sciences Inc (SSKN) has an overall rating of --, with a price target of 7.400.
What is the Earnings Per Share (EPS TTM) of STRATA Skin Sciences Inc (SSKN)?
The Earnings Per Share (EPS TTM) of STRATA Skin Sciences Inc (SSKN) is -2.626.